Patients with p@-positive oropharyngeal carcinoma ( OPC ) , compared with patients with p@-negative OPC , had better @-year probability of PFS ( @ % v. @ % , respectively ; P < @ ) and OS ( @ % v. @ % , respectively ; P < @ ) , but tumor epidermal growth factor receptor ( EGFR ) expression did not distinguish outcome .